Tunneling Nanotubes: A Novel Intercellular Communication Paradigm and Potential Epilepsy Treatment Approach
Neuropharmacology and Therapy · 2026 · 3
DOI: 10.15212/npt-2026-0007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropharmacology and Therapy, 2026. Verfasst von Yudan Zhu und 3 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tunneling nanotubes (TNTs) are F-actin-based membranous channels that enable direct transfer of organelles and signaling molecules between distant cells. Their formation is regulated by Myosin X (MYO10), Cell division control protein 42/Rac family small GTPase 1, and Phosphatidylinositol 3-kinase/Protein kinase B (PI3K/AKT) signaling, and is influenced by the extracellular microenvironment. TNTs lack specific markers and are identified by their characteristic intercellular bridge-like morphology. Physiologically, TNTs mediate mitochondrial transfer and developmental signal delivery, thereby maintaining tissue homeostasis and supporting embryogenesis, skin regeneration, and vesicle trafficking. Pathologically, TNTs exert bidirectional regulatory effects in multiple diseases. Their dysfunction contributes to peripheral neuropathy and neurodegeneration, whereas their aberrant activation promotes tumor drug resistance and pathogen spread. In epilepsy, abnormal TNT formation might exacerbate neuronal hyperexcitability, whereas functional TNTs might alleviate epileptiform activity by mediating mitochondrial transfer to damaged neurons. This Perspective systematically examines TNT regulatory mechanisms and physiological functions, and emphasizes their emerging roles in epilepsy. Therapeutic strategies targeting TNT modulation to restore neuronal energy homeostasis and suppress epileptiform activity are explored, including MYO10 gene editing, near-infrared light-controlled TNT dynamics, and ion channel-based regulation. TNTs, because of their roles as both pathological mediators and therapeutic targets, have potential in novel precision approaches for epilepsy and other refractory neurological disorders.
Zitieren
APA
Zhu, Y., Zeng, Y., Tang, L., & Tao, J. (2026). Tunneling Nanotubes: A Novel Intercellular Communication Paradigm and Potential Epilepsy Treatment Approach. Neuropharmacology and Therapy, 3. https://doi.org/10.15212/npt-2026-0007
Vancouver
Zhu Y, Zeng Y, Tang L, Tao J. Tunneling Nanotubes: A Novel Intercellular Communication Paradigm and Potential Epilepsy Treatment Approach. Neuropharmacology and Therapy. 2026;3. doi:10.15212/npt-2026-0007
BibTeX
@article{Zhu2026,
author = {Zhu, Yudan and Zeng, Yunqing and Tang, Lele and Tao, Jie},
title = {Tunneling Nanotubes: A Novel Intercellular Communication Paradigm and Potential Epilepsy Treatment Approach},
journal = {Neuropharmacology and Therapy},
year = {2026},
volume = {3},
doi = {10.15212/npt-2026-0007}
}
EUVIMED